2021
DOI: 10.26442/22217185.2021.1.200634
|View full text |Cite
|
Sign up to set email alerts
|

Pitavastatin: focus on safety and drug interactions

Abstract: Pitavastatin is a drug from the group of HMG-CoA reductase inhibitors, which has good lipid-lowering efficacy and has no significant effect on the risk of diabetes mellitus. This drug is non significantly metabolized by the P450 cytochrome system, which minimizes the risk of possible drug-drug interactions. Peptide organic anionic transporter inhibitors also may affect the efficacy and safety of the drug. This review summarizes the data on the problems of drug interactions of pitavastatin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
0
0
0
1
Order By: Relevance
“…В табл. 1 приведены данные о взаимодействии питавастатина с лекарствами, которые могут часто использоваться у пациентов, имеющих показания к назначению статинов [3].…”
Section:  особенности действия питавастатинаunclassified
“…В табл. 1 приведены данные о взаимодействии питавастатина с лекарствами, которые могут часто использоваться у пациентов, имеющих показания к назначению статинов [3].…”
Section:  особенности действия питавастатинаunclassified